down arrow

Enfusion, Inc.

  • Market Cap: Micro Cap
  • Industry: Packaged Software
  • ISIN: US2928121043
USD
10.76
-0.04 (-0.37%)

Apr 22

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

8.6611.80
Valuation
Technical
Day's Volume

CASH

0

Shareholding (Dec 2024)

FII

6.94%

Held by 58 FIIs

DII

35.92%

Held by 24 DIIs

Promoter

41.40%

How big is Enfusion, Inc.?

22-Jun-2025

As of Apr 22, Enfusion, Inc. has a market capitalization of 1,019.72 million, with net sales of 201.61 million and a net profit of 3.92 million for the latest four quarters. The balance sheet shows shareholder's funds of 73.22 million and total assets of 143.26 million.

As of Apr 22, Enfusion, Inc. has a market capitalization of 1,019.72 million, categorizing it as a Micro Cap company.<BR><BR>As of Apr 22, the company reported net sales of 201.61 million and a net profit of 3.92 million for the latest four quarters ending in December 2024, September 2024, June 2024, and March 2024.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 73.22 million and total assets of 143.26 million.

Read More

What does Enfusion, Inc. do?

22-Jun-2025

Enfusion, Inc. is a micro-cap company in the packaged software industry, reporting net sales of $53 million and a market cap of approximately $1.02 billion as of December 2024. Key metrics include a P/E ratio of 260.00 and a dividend yield of 101.02%.

Overview: <BR>Enfusion, Inc. operates in the packaged software industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 53 Million (Quarterly Results - Dec 2024) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Dec 2024) <BR>Market-cap: USD 1,019.72 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 260.00 <BR>Dividend Yield: 101.02% <BR>Debt Equity: -0.66 <BR>Return on Equity: 5.35% <BR>Price to Book: 13.93<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Packaged Software

stock-summary
Market cap

USD 1,020 Million (Micro Cap)

stock-summary
P/E

260.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

101.02%

stock-summary
Debt Equity

-0.66

stock-summary
Return on Equity

5.35%

stock-summary
Price to Book

13.93

Revenue and Profits:
Net Sales:
53 Million
(Quarterly Results - Dec 2024)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.8%
0%
-2.8%
6 Months
22.13%
0%
22.13%
1 Year
15.7%
0%
15.7%
2 Years
12.67%
0%
12.67%
3 Years
-5.7%
0%
-5.7%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Enfusion, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
189.12%
EBIT Growth (5y)
49.05%
EBIT to Interest (avg)
-14.80
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.66
Sales to Capital Employed (avg)
2.67
Tax Ratio
47.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
92.87%
ROCE (avg)
19.58%
ROE (avg)
5.69%
Valuation key factors
Factor
Value
P/E Ratio
260
Industry P/E
Price to Book Value
13.93
EV to EBIT
157.81
EV to EBITDA
62.63
EV to Capital Employed
39.14
EV to Sales
4.82
PEG Ratio
NA
Dividend Yield
101.02%
ROCE (Latest)
24.80%
ROE (Latest)
5.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 41 Schemes (15.73%)

Foreign Institutions

Held by 58 Foreign Institutions (6.94%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 13.76% vs 14.81% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -77.78% vs 12.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.90",
          "val2": "46.50",
          "chgp": "13.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.40",
          "val2": "4.20",
          "chgp": "-42.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.20",
          "val2": "0.90",
          "chgp": "-77.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.90%",
          "val2": "45.90%",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.53% vs 16.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -59.38% vs 172.18% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "201.60",
          "val2": "174.50",
          "chgp": "15.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.50",
          "val2": "20.50",
          "chgp": "-24.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.90",
          "val2": "9.60",
          "chgp": "-59.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.50%",
          "val2": "68.50%",
          "chgp": "-3.80%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
52.90
46.50
13.76%
Operating Profit (PBDIT) excl Other Income
2.40
4.20
-42.86%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.20
0.90
-77.78%
Operating Profit Margin (Excl OI)
29.90%
45.90%
-1.60%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 13.76% vs 14.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -77.78% vs 12.50% in Dec 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
201.60
174.50
15.53%
Operating Profit (PBDIT) excl Other Income
15.50
20.50
-24.39%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.90
9.60
-59.38%
Operating Profit Margin (Excl OI)
30.50%
68.50%
-3.80%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 15.53% vs 16.10% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -59.38% vs 172.18% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Enfusion, Inc. stock-summary
stock-summary
Enfusion, Inc.
Packaged Software
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."